Traws Pharma Inc (TRAW)
8.07
-0.96
(-10.63%)
USD |
NASDAQ |
Jan 08, 16:00
8.15
+0.08
(+0.99%)
After-Hours: 20:00
Traws Pharma Enterprise Value: 19.01M for Jan. 8, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Phio Pharmaceuticals Corp | -3.607M |
| Design Therapeutics Inc | 33.28M |
| Emergent BioSolutions Inc | 1.059B |
| Marinus Pharmaceuticals Inc | 42.38M |
| NovaBay Pharmaceuticals Inc | 2.400M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.475M |
| Revenue (Quarterly) | 0.057M |
| Total Expenses (Quarterly) | 8.593M |
| EPS Diluted (Quarterly) | -8.81 |
| Profit Margin (Quarterly) | -14.87K% |
| Earnings Yield | -1.75K% |
| Normalized Earnings Yield | -315.34 |